Endologix, Inc. Completes Its Acquisition of Nellix, Inc.

Endologix, Inc.

Represented Endologix, Inc. in its acquisition of Nellix, Inc., up to $54 million.

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA).